Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Joseph Benesch is CFO at Journey Medical. OQRO lists 4 transactions filed with the SEC under this name, the latest on Apr 24, 2026, each linked to the official Form 4.
CFO
Disclosures on record
4
Companies involved
1
As of the latest filing on , Joseph Benesch reported holding 261,371 shares of Journey Medical (DERM), worth about $967K at the last close of $4 (Nov 16, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Journey Medical DERM | 261,371 | 261K direct | $4 | $967K | Apr 22, 2026 |
Is this Joseph Benesch’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Journey MedicalDERM
4 disclosures · Feb 2025 – Apr 2026 · 2 sold
Apr 22, 202629Kdisclosed Apr 24
DetailsOfficial recordApr 22, 202642Kdisclosed Apr 24
DetailsOfficial recordMay 2, 2025Sold~$16Kdisclosed May 5
DetailsOfficial recordFeb 21, 2025Sold~$7.1Kdisclosed Feb 24
DetailsOfficial recordJoseph Benesch has no open-market purchase on record since 2023. Sales in each of the last 3 years.
Joseph Benesch reported 0 open-market purchases and 7 sales since 2023; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $24K2×2 trades |
| 2024 | — | $82K3×3 trades |
| 2023 | — | $13K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Apr 22, 2026, Joseph Benesch reported holding 261,371 shares of Journey Medical (DERM). At the last close of $4 on Nov 16, 2026, that is about $967K. This is the stake disclosed in filings, not a net worth.
Joseph Benesch has no open-market purchase on record since 2023. Sales in each of the last 3 years.
In SEC filings since 2023: no open-market purchase is on record; the latest open-market sale is from 2025.
Journey Medical (DERM), from 2023 to 2025: 0 purchases and 7 sales.
Joseph Benesch reported 0 open-market purchases and 7 sales here, 2023 to 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.